Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.35 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26025737 | 1.00 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL24725791 | 1.00 | GSR (0.52) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL21342395 | 0.82 | CA12 (0.45) | GSRGNAI3GNAO1GNAI1PAOX | |
| SCHEMBL13086099 | 0.82 | GSR (0.48) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL19596576 | 0.81 | OPRM1 (0.48) | GNAI3GNAO1GNAI1DPP7CYP1A2 | |
| SCHEMBL26025316 | 0.81 | OPRM1 (0.48) | GNAI3GNAO1GNAI1DPP7CYP1A2 | |
| SCHEMBL14605594 | 0.81 | OPRM1 (0.48) | GNAI3GNAO1GNAI1DPP7CYP1A2 | |
| SCHEMBL20734476 | 0.79 | SPHK1 (0.48) | GNAI3GNAO1GNAI1DPP7CYP1A2 | |
| SCHEMBL19650484 | 0.79 | SPHK1 (0.48) | GNAI3GNAO1GNAI1DPP7CYP1A2 | |
| SCHEMBL1437432 | 0.79 | GSR (0.55) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3670494-B1 | PRODUCTION OF LYSINATE COMPOUND FROM AN AQUEOUS LYSIN SOLUTION | PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH (DE) | 2023-06-14 | — | — | EP | disclosed |
| EP-4190795-A1 | COMPOUND, AND LABELED BIOLOGICAL SUBSTANCE IN WHICH SAME IS USED | FUJIFILM Corporation (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-20220267303-A1 | Compounds and Methods for Treating or Preventing Bacterial Infections | BAYLOR COLLEGE OF MEDICINE | 2022-08-25 | — | — | US | disclosed |
| WO-2022079653-A1 | ORAL PYROPHOSPHATE FOR USE IN REDUCING CALCIFICATION | PYROGENYX INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| EP-2052011-B1 | TARGETED POLYLYSINE DENDRIMER THERAPEUTIC AGENT | STARPHARMA PTY LTD (AU) | 2020-11-04 | — | — | EP | disclosed |
| EP-2373302-B1 | THE USE OF COMPOUNDS TO INHIBIT 5alpha-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM | GIULIANI SPA (IT) | 2017-09-13 | — | — | EP | disclosed |
| EP-3144324-A1 | CHITOSAN-DERIVATIVE COMPOUNDS AND METHODS OF CONTROLLING MICROBIAL POPULATIONS | Synedgen, Inc. (US) | 2017-03-22 | — | — | EP | disclosed |
| WO-2017031288-A1 | STABLE ANTI-IFNAR1 FORMULATION | MEDIMMUNE, LLC (US) | 2017-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267303-A1 | Compounds and Methods for Treating or Preventing Bacterial Infections | OXA1L, MMP8, OGG1 | GSR 1929/4885GNAI3 2920/4885GNAO1 1977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.